BSBarré Soropogui

Barré Soropogui

*This is an algorithmically generated author record based on publicly available information.

Barré Soropogui has a total of 60 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Leptospirosis in the republic of guinea

    by Regina R. Baimova, I. A. Karmokov, E. G. Riabiko, E. S. Khalilov, O. V. Blinova, N. K. Tokarevich, S. Boumbaly, B. Soropogui, A. Camara, J. Camara, et al.

    Leptospirosis is an acute zoonotic infection caused by pathogenic bacteria from the genus Leptospira. Leptospirosis creates significant though underdiagnosed public health problems in Africa. The Republic of Guinea (Guinea) is a country in West Africa, its capital is Conakry. The study objective was to assess the prevalence of the leptospirosis in febrile patients in the Republic of Guinea. We analyzed 827 blood serum samples obtained from febrile patients who applied to municipal health services, in the period from 2020 to 2024. RT-PCR was used to test 627 blood serum samples for the presence of genetic material of pathogenic Leptospira spp. Genotyping of positive samples was performed with the help of primers selected for a fragment of the secY gene. As a result of our study, IgG antibodies to Leptospira spp. were detected in 202 blood serum samples, which amounted to 24.4%.154 blood serum samples (18.6%) were positive for IgM to Leptospira spp. In 80 of the 276 positive samples both antibodies (IgG and IgM) were detected, 122 samples contained only IgG, while 74 only IgM. Leptospira spp. DNA was detected in 5 (0.8%) of 657 serum samples tested for the presence genetic markers of pathogenic leptospira. Sanger sequencing was applied to all 5 samples, and for three samples it resulted in successful leptospira genotyping, but it failed for two other samples may be due to insufficient amount of DNA or its degradation. When analyzed according to the BLAST algorithm, the obtained sequences revealed 100% similarity to those of L. kirschneri that was further confirmed by clustering when constructing the phylogenetic tree. Our study revealed high level of antibodies to leptospirosis in febrile patients, which bear witness to the wide spread of this pathogen in the Republic of Guinea. Joint research with international organizations can provide valuable information on the epidemiology of leptospirosis and improve control and prevention of the disease.

  • Open Access

    Diversity of Leptospira Species and Their Rodent Reservoirs in the Guinean Forest

    by Siba Pricemou, Barré Soropogui, Fanta Bérété, Michel Bossou Beavogui, Aboubacar Samoura, Mathieu Picardeau, Pascale Bourhy, Noël Tordo, Solène Grayo

    Leptospirosis is a bacterial zoonosis caused by pathogenic species from the genus Leptospira. Infection mostly occurs through indirect contact with environmental water contaminated with the urine of reservoir animals. Information on the circulation of leptospirosis in West Africa, as well as its potential reservoir hosts, is limited. Therefore, we carried out trapping surveys in the Guinean forest in November 2022, and samples were collected from 42 micromammals. The animals were both morphologically and genetically identified. The lungs and kidneys were screened for Leptospira using Lfb1-gene-targeting real-time PCR, and positive samples were genotyped based on the polymorphic Lfb1 gene. Leptospira species were detected in the kidneys of three micromammals: Mastomys natalensis, Lophuromys sikapusi, and Rattus rattus. Leptospira borgpetersenii was identified in Rattus rattus and Mastomys natalensis that were captured in two different villages. The phylogenetic analysis indicated that this subspecies had previously been detected in one patient in Mayotte, but the reservoir was not identified. A new subspecies of Leptospira kirschneri was isolated in Lophuromys sikapusi from the same village as the Mastomys natalensis positive for L. borgpetersenii. The high diversity of both the reservoirs and Leptospira species in the Guinean forest indicates that we should study other natural regions and reinforce communities’ awareness of Leptospira infection risks in Guinea.


  • Open Access

    A Sporadic and Lethal Lassa Fever Case in Forest Guinea, 2019

    by N’faly Magassouba, Enogo Koivogui, Sory Conde, Moussa Kone, Michel Koropogui, Barrè Soropogui, Ifono Kekoura, Julia Hinzmann, Stephan Günther, Sakoba Keita, et al.

    Lassa fever is a rodent-borne disease caused by Lassa virus (LASV). It causes fever, dizziness, vertigo, fatigue, coughing, diarrhea, internal bleeding and facial edema. The disease has been known in Guinea since 1960 but only anectodical acute cases have been reported to date. In January 2019, a 35-year-old man, a wood merchant from Kissidougou, Forest Guinea, presented himself at several health centers with persistent fever, frequent vomiting and joint pain. He was repeatedly treated for severe malaria, and died three weeks later in Mamou regional hospital. Differential diagnosis identified LASV as the cause of death. No secondary cases were reported. The complete LASV genome was obtained using next-generation sequencing. Phylogenetic analysis showed that this strain, namely the Kissidougou strain, belongs to the clade IV circulating in Guinea and Sierra Leone, and is thought to have emerged some 150 years ago. Due to the similarity of symptoms with malaria, Lassa fever is still a disease that is difficult to recognize and that may remain undiagnosed in health centers in Guinea.


  • Open Access

    Comparative performance study of three Ebola rapid diagnostic tests in Guinea

    by Zelda Moran, William Rodriguez, Doré Ahmadou, Barré Soropogui, N’ Faly Magassouba, Cassandra Kelly-Cirino, Yanis Ben Amor

    Background: The 2014/15 Ebola outbreak in West Africa resulted in 11,000 deaths and massive strain on local health systems, and the ongoing outbreak in Democratic Republic of Congo has afflicted more than 3000 people. Accurate, rapid Ebola diagnostics suitable for field deployment would enable prompt identification and effective response to future outbreaks, yet remain largely unavailable. The purpose of this study was to assess the accuracy of three novel rapid diagnostic tests (RDTs): an Ebola, an Ebola-Malaria, and a Fever Panel test that includes Ebola, all from a single manufacturer. Methods: We evaluated the three RDTs in 109 Ebola-positive and 96 Ebola-negative stored serum samples collected during the outbreak in Guinea in 2014/15, and tested by real-time polymerase chain reaction (RT-PCR). Sensitivity, specificity, and overall percent agreement were calculated for each RDT using RT-PCR as a reference standard, stratified by Ct value ranges. Results: All tests performed with high accuracy on samples with low Ct value (high viral load). The Fever Panel test performed with the highest accuracy, with a sensitivity of 89.9% and specificity of 90.6%. The Ebola and Ebola-Malaria tests performed comparably to each other: sensitivity was 77.1 and 78% respectively, and specificity was 91.7% for the Ebola test and 95.8% for the Ebola-Malaria test. Conclusions: This study evaluated the accuracy of three novel rapid diagnostic tests for Ebola. The tests may have significant public health relevance, particularly the Fever Panel test, which detects seven pathogens including Ebola. Given limitations to the study resulting from uncertain sample quality, further evaluation is warranted. All tests performed with highest accuracy on samples with low Ct value (high viral load), and the data presented here suggests that these RDTs may be useful for point-of-care diagnosis of cases in the context of an outbreak. Restrictions to their use in non-severe Ebola cases or for longitudinal monitoring, when viral loads are lower, may be appropriate. Highlighting the challenge in developing and evaluating Ebola RDTs, there were concerns regarding sample integrity and reference testing, and there is a need for additional research to validate these assays.


  • Open Access

    Molecular Diagnostics of Ebola Patient Samples by Institut Pasteur de Dakar Mobile Laboratory in Guinea 2014–2016

    by Oumar Faye, Cheikh Tidiane Diagne, Amadou Diallo, Emily Meyer, Barre Soropogui, Gamou Fall, Cheikh Fall, N’faly Magassouba, Lamine Koivogui, Sakoba Keita, et al.

    As part of the laboratory response to the Ebola virus outbreak in Guinea, the Institut Pasteur de Dakar mobile laboratory (IPD-ML) was set up in Donka hospital from 2014 to 2016. EBOV suspected samples collected at Ebola Treatment Centers (ETC) and from community deaths were sent daily to IPD-ML. Analysis was performed using dried oligonucleotide mixes for real-time RT-PCR designed for field diagnostic. From March 2014 to May 2015, a total of 6055 patient samples suspected for EBOV collected from seven regions of Guinea were tested by real-time RT-PCR. These patients’ clinical included serum samples (n = 2537 samples) and swabs (n = 3518 samples) with positivity rates of 36.74 and 6.88% respectively. Females were significantly more affected than males with positivity rates of 22.39 and 17.22% respectively (p-value = 5.721e-7). All age groups were exposed to the virus with significant difference (p-value <= 2.2e-16). The IPD-ML contributed significantly to the surveillance and patient management during the EBOV outbreak in Guinea. Furthermore, dried reagents adapted for field diagnostic of EVD suspect cases could be useful for future outbreak preparedness and response.


  • Open Access

    No measurable adverse effects of Lassa, Morogoro and Gairo arenaviruses on their rodent reservoir host in natural conditions

    by Joachim Mariën, Benny Borremans, Sophie Gryseels, Barré Soropogui, Luc De Bruyn, Gédéon Ngiala Bongo, Beate Becker-Ziaja, Joëlle Goüy de Bellocq, Stephan Günther, N’fAly Magassouba, et al.

    In order to optimize net transmission success, parasites are hypothesized to evolve towards causing minimal damage to their reservoir host while obtaining high shedding rates. For many parasite species however this paradigm has not been tested, and conflicting results have been found regarding the effect of arenaviruses on their rodent host species. The rodent Mastomys natalensis is the natural reservoir host of several arenaviruses, including Lassa virus that is known to cause Lassa haemorrhagic fever in humans. Here, we examined the effect of three arenaviruses (Gairo, Morogoro and Lassa virus) on four parameters of wild-caught Mastomys natalensis: body mass, head-body length, sexual maturity and fertility. After correcting for the effect of age, we compared these parameters between arenavirus-positive (arenavirus RNA or antibody) and negative animals using data from different field studies in Guinea (Lassa virus) and Tanzania (Morogoro and Gairo viruses). Although the sample sizes of our studies (1297, 749 and 259 animals respectively) were large enough to statistically detect small differences in body conditions, we did not observe any adverse effects of these viruses on Mastomys natalensis. We did find that sexual maturity was significantly positively related with Lassa virus antibody presence until a certain age, and with Gairo virus antibody presence in general. Gairo virus antibody-positive animals were also significantly heavier and larger than antibody-free animals. Together, these results suggest that the pathogenicity of arenaviruses is not severe in M. natalensis, which is likely to be an adaptation of these viruses to optimize transmission success. They also suggest that sexual behaviour might increase the probability of M. natalensis to become infected with arenaviruses.